VANGUARD GROUP INC - EDGEWISE THERAPEUTICS INC ownership

EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 86 filers reported holding EDGEWISE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 3.56 and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of EDGEWISE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,829,132
-24.9%
2,064,421
+1.6%
0.00%
Q2 2023$15,747,682
+17.7%
2,031,959
+1.3%
0.00%
Q1 2023$13,378,853
-24.5%
2,005,825
+1.2%
0.00%
Q4 2022$17,728,056
+2.8%
1,983,004
+13.2%
0.00%
-100.0%
Q3 2022$17,239,000
+76.6%
1,751,845
+42.8%
0.00%
Q2 2022$9,763,000
-16.9%
1,226,568
+1.3%
0.00%
Q1 2022$11,748,000
-35.9%
1,211,093
+1.0%
0.00%
Q4 2021$18,326,000
+87.9%
1,199,400
+104.1%
0.00%
Q3 2021$9,753,000
-21.5%
587,521
+0.8%
0.00%
Q2 2021$12,432,000
+218.8%
582,863
+385.7%
0.00%
Q1 2021$3,900,000120,0000.00%
Other shareholders
EDGEWISE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,553,661$15,071,0007.43%
Cormorant Asset Management, LP 4,682,874$45,424,0003.49%
Novo Holdings A/S 5,587,207$54,196,0002.86%
Orbimed Advisors 13,944,680$135,263,0002.19%
Opaleye Management Inc. 303,000$2,939,0000.91%
DAFNA Capital Management LLC 356,750$3,460,0000.90%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,933,137$38,151,0000.85%
EcoR1 Capital, LLC 2,359,808$22,890,0000.72%
RA Capital Management 2,613,623$25,352,0000.55%
HighVista Strategies LLC 59,733$579,0000.37%
View complete list of EDGEWISE THERAPEUTICS INC shareholders